Tomoko Asakawa

Discovery of Alogliptin:  A Potent, Selective, Bioavailable, and Efficacious Inhibitor of Dipeptidyl Peptidase IV

Jun Feng, Zhiyuan Zhang, Michael B. Wallace et al. · Journal of Medicinal Chemistry · 2007 · 404 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Multiple polyamine transport systems on the vacuolar membrane in yeast

Hideyuki Tomitori, Keiko Kashiwagi, Tomoko Asakawa et al. · Biochemical Journal · 2001 · 120 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Multiple polyamine transport systems on the vacuolar membrane in yeast

Hideyuki Tomitori, Keiko Kashiwagi, Tomoko Asakawa et al. · Biochemical Journal · 2001 · 88 citations

Life Sciences, Biochemistry, Molecular Biology +13

Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys

Bumsup Lee, Lihong Shi, Daniel B. Kassel et al. · European Journal of Pharmacology · 2008 · 87 citations

Medicine, Pharmacokinetics, Pharmacology +13

Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice

Yusuke Moritoh, Koji Takeuchi, Tomoko Asakawa et al. · European Journal of Pharmacology · 2008 · 74 citations

Medicine, Endocrinology, Pharmacology +14